These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 21238604
1. Exposure to asbestos: correlation between blood levels of mesothelin and frequency of micronuclei in peripheral blood lymphocytes. Marini V, Michelazzi L, Cioé A, Fucile C, Spigno F, Robbiano L. Mutat Res; 2011 Mar 18; 721(1):114-7. PubMed ID: 21238604 [Abstract] [Full Text] [Related]
2. Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure. Rodríguez Portal JA, Rodríguez Becerra E, Rodríguez Rodríguez D, Alfageme Michavila I, Quero Martínez A, Diego Roza C, León Jiménez A, Isidro Montes I, Cebollero Rivas P. Cancer Epidemiol Biomarkers Prev; 2009 Feb 18; 18(2):646-50. PubMed ID: 19190155 [Abstract] [Full Text] [Related]
3. Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein. Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Bruno R, Landi D, Gemignani F, Landi S. Occup Environ Med; 2010 Apr 18; 67(4):233-6. PubMed ID: 19858537 [Abstract] [Full Text] [Related]
4. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J. Ann Thorac Surg; 2008 Jan 18; 85(1):265-72; discussion 272. PubMed ID: 18154821 [Abstract] [Full Text] [Related]
5. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein. Creaney J, Robinson BW. Hematol Oncol Clin North Am; 2005 Dec 18; 19(6):1025-40, v. PubMed ID: 16325121 [Abstract] [Full Text] [Related]
6. Investigation of micronucleus frequencies in lymphocytes of inhabitants environmentally exposed to chrysotile asbestos. Dönmez-Altuntas H, Baran M, Oymak FS, Hamurcu Z, Imamoğlu N, Ozesmi M, Demirtas H. Int J Environ Health Res; 2007 Feb 18; 17(1):45-51. PubMed ID: 17365079 [Abstract] [Full Text] [Related]
7. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study. Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K. Lung Cancer; 2008 Aug 18; 61(2):235-43. PubMed ID: 18281122 [Abstract] [Full Text] [Related]
8. Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. Park EK, Sandrini A, Yates DH, Creaney J, Robinson BW, Thomas PS, Johnson AR. Am J Respir Crit Care Med; 2008 Oct 15; 178(8):832-7. PubMed ID: 18583574 [Abstract] [Full Text] [Related]
9. Soluble mesothelin-related protein--a blood test for mesothelioma. Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. Lung Cancer; 2005 Jul 15; 49 Suppl 1():S109-11. PubMed ID: 15950789 [Abstract] [Full Text] [Related]
10. High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma. Bolognesi C, Filiberti R, Neri M, Perrone E, Landini E, Canessa PA, Simonassi C, Cerrano PG, Mutti L, Puntoni R. Cancer Res; 2002 Oct 01; 62(19):5418-9. PubMed ID: 12359747 [Abstract] [Full Text] [Related]
11. Mesothelin (MSLN) methylation and soluble mesothelin-related protein levels in a Chinese asbestos-exposed population. Yu M, Zhang Y, Jiang Z, Chen J, Liu L, Lou J, Zhang X. Environ Health Prev Med; 2015 Sep 01; 20(5):369-78. PubMed ID: 26188910 [Abstract] [Full Text] [Related]
12. Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population. Park EK, Thomas PS, Creaney J, Johnson AR, Robinson BW, Yates DH. Clin Chem Lab Med; 2010 Jun 01; 48(6):869-74. PubMed ID: 20345230 [Abstract] [Full Text] [Related]
13. Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer. Cristaudo A, Foddis R, Vivaldi A, Guglielmi G, Dipalma N, Filiberti R, Neri M, Ceppi M, Paganuzzi M, Ivaldi GP, Mencoboni M, Canessa PA, Ambrosino N, Chella A, Mutti L, Puntoni R. Clin Cancer Res; 2007 Sep 01; 13(17):5076-81. PubMed ID: 17785560 [Abstract] [Full Text] [Related]
14. Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos. Gube M, Taeger D, Weber DG, Pesch B, Brand P, Johnen G, Müller-Lux A, Gross IM, Wiethege T, Weber A, Raithel HJ, Kraus T, Brüning T. Arch Toxicol; 2011 Mar 01; 85(3):185-92. PubMed ID: 20737138 [Abstract] [Full Text] [Related]
15. Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure. Demir M, Kaya H, Taylan M, Ekinci A, Yılmaz S, Teke F, Sezgi C, Tanrikulu AC, Meteroglu F, Senyigit A. Lung; 2016 Jun 01; 194(3):409-17. PubMed ID: 27032653 [Abstract] [Full Text] [Related]
16. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, Grégoire M, Porte H, Copin MC, Lassalle P. Clin Cancer Res; 2007 May 15; 13(10):2928-35. PubMed ID: 17504993 [Abstract] [Full Text] [Related]
17. Comparison of micronuclei frequencies in mono-, bi- and poly-nucleated lymphocytes from subjects of a residential suburb and subjects living near a metallurgical plant. Martelli A, Robbiano L, Cosso M, Perrone C, Tagliazucchi A, Giuliano L, Aresca GF, Brambilla G. Mutat Res; 2000 Oct 31; 470(2):211-9. PubMed ID: 11027976 [Abstract] [Full Text] [Related]
18. Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels. Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Bruno R, Gemignani F, Landi S. Int J Biol Markers; 2011 Oct 31; 26(2):117-23. PubMed ID: 21574151 [Abstract] [Full Text] [Related]